Keywords: AstraZeneca, Apotex, Pulmicort, Eli Lilly, Gemzar, Teva

US Appeal Court backs preliminary injunction against Apotex over AstraZeneca’s Pulmicort Respules; rejects Eli Lilly’s Gemzar appeal

Article | 03 November 2010

Print This

Anglo-Swedish major AstraZeneca (LSE: AZN) says the US Court of Appeals for the Federal Circuit affirmed the District Court’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in